The Europe Herpes Simplex Virus Treatment Market would witness market growth of 2.8% CAGR during the forecast period (2022-2028).
The pipeline of vaccine candidates is anticipated to be released on the market throughout the forecast period. For example, GSK is working on the GSK4108771A vaccine, Sanofi Pasteur is developing the HSV529 vaccine, and RVx201 is a vaccine for HSV-2 that is a live attenuated vaccine. Moreover, EXD-12 is now undergoing preclinical testing. Moreover, efforts are being made by significant market participants to create and market vaccine candidates that are appropriate for herpes infection. For instance, research is being done to create highly effective, safe, and effective mRNA vaccine candidates. For instance, Moderna Inc. is working on mRNA-1608, a candidate for an mRNA vaccine.
Additionally, the efficiency and simplicity of administration of oral medication for herpes have significantly increased their demand. Oral versions of acyclovir, famciclovir, and valacyclovir are offered. Acyclovir, when taken orally, also lessens the average length of cold sore pain compared to a placebo, according to multiple research. In addition, acyclovir, administered orally, has a faster healing period than other therapy formulations. Moreover, oral formulations aid in delivering quick action, improving its appeal among the populace.
The prevalence of HSV-1 infection among young adults is lower in Northern European nations. European women are far more likely than European men to be HSV-1 seropositive. Although there are significant variances in the proportion of people exposed to HSV-2, HSV-2 seropositivity is commonly found among Europeans over 12 years of age. Compared to other European nations, Bulgaria has a high HSV-2 seroprevalence. In every European nation, HSV-2 seropositivity rises with age and becomes more prevalent in the population, with some nations seeing a reduction in the older age groups. Therefore, the increasing prevalence of HSV infections and the research initiatives looking for better medications will drive the regional market's growth in the coming years.
The Germany market dominated the Europe Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $140.9 Million by 2028. The UK market is anticipated to grow at a CAGR of 1.9% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 3.5% during (2022 - 2028).
Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Herpes Simplex Virus Treatment Market will Hit $2.1 Billion by 2028, at a CAGR of 3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Valacyclovir
- Acyclovir
- Famciclovir
By Type
- Herpes simplex virus-1 Infection
- Herpes simplex virus-2 Infection
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Pfizer, Inc.
- Amneal Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Fresenius SE & Co. KGaA
- Novartis AG
- Viatris, Inc.
- Emcure Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Herpes Simplex Virus Treatment Market, by Drug Type
1.4.2 Europe Herpes Simplex Virus Treatment Market, by Type
1.4.3 Europe Herpes Simplex Virus Treatment Market, by Distribution Channel
1.4.4 Europe Herpes Simplex Virus Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Herpes Simplex Virus Treatment Market by Drug Type
3.1 Europe Valacyclovir Market by Country
3.2 Europe Acyclovir Market by Country
3.3 Europe Famciclovir Market by Country
Chapter 4. Europe Herpes Simplex Virus Treatment Market by Type
4.1 Europe Herpes simplex virus-1 Infection Market by Country
4.2 Europe Herpes simplex virus-2 Infection Market by Country
Chapter 5. Europe Herpes Simplex Virus Treatment Market by Distribution Channel
5.1 Europe Drug Store & Retail Pharmacies Market by Country
5.2 Europe Hospital Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country
Chapter 6. Europe Herpes Simplex Virus Treatment Market by Country
6.1 Germany Herpes Simplex Virus Treatment Market
6.1.1 Germany Herpes Simplex Virus Treatment Market by Drug Type
6.1.2 Germany Herpes Simplex Virus Treatment Market by Type
6.1.3 Germany Herpes Simplex Virus Treatment Market by Distribution Channel
6.2 UK Herpes Simplex Virus Treatment Market
6.2.1 UK Herpes Simplex Virus Treatment Market by Drug Type
6.2.2 UK Herpes Simplex Virus Treatment Market by Type
6.2.3 UK Herpes Simplex Virus Treatment Market by Distribution Channel
6.3 France Herpes Simplex Virus Treatment Market
6.3.1 France Herpes Simplex Virus Treatment Market by Drug Type
6.3.2 France Herpes Simplex Virus Treatment Market by Type
6.3.3 France Herpes Simplex Virus Treatment Market by Distribution Channel
6.4 Russia Herpes Simplex Virus Treatment Market
6.4.1 Russia Herpes Simplex Virus Treatment Market by Drug Type
6.4.2 Russia Herpes Simplex Virus Treatment Market by Type
6.4.3 Russia Herpes Simplex Virus Treatment Market by Distribution Channel
6.5 Spain Herpes Simplex Virus Treatment Market
6.5.1 Spain Herpes Simplex Virus Treatment Market by Drug Type
6.5.2 Spain Herpes Simplex Virus Treatment Market by Type
6.5.3 Spain Herpes Simplex Virus Treatment Market by Distribution Channel
6.6 Italy Herpes Simplex Virus Treatment Market
6.6.1 Italy Herpes Simplex Virus Treatment Market by Drug Type
6.6.2 Italy Herpes Simplex Virus Treatment Market by Type
6.6.3 Italy Herpes Simplex Virus Treatment Market by Distribution Channel
6.7 Rest of Europe Herpes Simplex Virus Treatment Market
6.7.1 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type
6.7.2 Rest of Europe Herpes Simplex Virus Treatment Market by Type
6.7.3 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Fresenius SE & Co. KGaA
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Viatris, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Research & Development Expense
7.10. Emcure Pharmaceuticals Limited
7.10.1 Company Overview
TABLE 1 Europe Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 2 Europe Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 3 Europe Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 Europe Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 Europe Valacyclovir Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Valacyclovir Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Acyclovir Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Acyclovir Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Famciclovir Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Famciclovir Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 12 Europe Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 13 Europe Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 Europe Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
TABLE 27 Germany Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 28 Germany Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 29 Germany Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 30 Germany Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 31 Germany Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 32 Germany Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 33 Germany Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 Germany Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 UK Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 36 UK Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 37 UK Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 38 UK Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 39 UK Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 40 UK Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 41 UK Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 UK Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 France Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 44 France Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 45 France Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 France Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 France Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 48 France Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 49 France Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 France Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 Russia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 52 Russia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 53 Russia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 54 Russia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 55 Russia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 56 Russia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 57 Russia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Russia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Spain Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 60 Spain Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 61 Spain Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 62 Spain Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 63 Spain Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 64 Spain Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 65 Spain Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Spain Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Italy Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 68 Italy Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 69 Italy Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 70 Italy Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 71 Italy Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 72 Italy Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 73 Italy Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Italy Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Rest of Europe Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 76 Rest of Europe Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 77 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 78 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 Key Information – Amneal Pharmaceuticals, INc.
TABLE 86 Key Information – GlaxoSmithKline PLC
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key Information – Glenmark Pharmaceuticals Limited
TABLE 89 key information – Fresenius SE & Co. KGaA
TABLE 90 Key Information – Novartis AG
TABLE 91 key information – Viatris, Inc.
TABLE 92 Key Information – Emcure Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories